Liquidia Corp

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences | Liquidia Corporation

Press release Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences November 3, 2025 PDF Version MORRISVILLE, N.C. , Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’s executive leadership team will be providing updates on the company's business during fireside chats at the following two investor conferences in November: 2025 UBS Global Healthcare Conference on Monday, November 10 beginning at 4:15 p.m. ET in Palm Beach Gardens, Florida Jefferies London Healthcare Conference on Tuesday, November 18 beginning at 8 :00 a.m. ET / 1:00 p.m. GMT Access to webcasts of both presentations will be available to investors and other interested parties by accessing Liquidia’s website at https://liquidia.

Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference | Liquidia Corporation

Press release Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference January 7, 2026 PDF Version MORRISVILLE, N.C. , Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs , Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15 p.m. Pacific Time ( 8:15 p.m. Eastern Time ) at the Westin St. Francis in San Francisco, California . Access to a live, audio-only webcast will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations . The webcast will be archived on the company's website for at least 30 days. About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with cha

Liquidia Corporation to Participate in Upcoming Investor Conferences | Liquidia Corporation

Press release Liquidia Corporation to Participate in Upcoming Investor Conferences April 7, 2026 PDF Version MORRISVILLE, N.C. , April 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced it will participate in upcoming investor conferences. 2026 Raymond James Biotech Innovation Symposium Date: Tuesday, April 14, 2026 Location: Lotte New York Palace , New York, NY Michael Kaseta , Chief Operating Officer and Chief Financial Officer, and Jason Adair , Chief Business Officer, will participate in one-on-one investor meetings. 25th Annual Needham Virtual Healthcare Conference Date: Wednesday, April 15, 2026 Location: Virtual Event In addition to hosting one-on-one meetings, Dr. Roger Jeffs , Chief Executive Offi

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 | Liquidia Corporation

Press release Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 October 7, 2025 PDF Version MORRISVILLE, N.C. , Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Development Day (R&D Day) on Tuesday, October 28, 2025 , in New York City which will be webcast from 2:00 p.m. to 4:30 p.m. Eastern Standard Time . The event will feature presentations from Liquidia’s management team alongside three key opinion leaders (KOLs) in the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The agenda will focus on L606 (treprostinil liposome inhalation suspension), an investigational sustained-release formulation, and include a cli